Compounds > vx 497
Page last updated: 2024-09-04

vx 497 and ifenprodil

vx 497 has been researched along with ifenprodil in 1 studies

Compound Research Comparison

Studies
(vx 497)		Trials
(vx 497)		Recent Studies (post-2010)
(vx 497)		Studies
(ifenprodil)		Trials
(ifenprodil)		Recent Studies (post-2010) (ifenprodil)
253768510207

Protein Interaction Comparison

ProteinTaxonomyvx 497 (IC50)ifenprodil (IC50)
Alpha-1B adrenergic receptorRattus norvegicus (Norway rat)0.105
Alpha-1D adrenergic receptorRattus norvegicus (Norway rat)0.105
Histamine H1 receptorHomo sapiens (human)1
Glutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)0.168
Alpha-1A adrenergic receptorRattus norvegicus (Norway rat)0.105
Glutamate receptor ionotropic, NMDA 2A Rattus norvegicus (Norway rat)0.263
Glutamate receptor ionotropic, NMDA 2BRattus norvegicus (Norway rat)0.168
Glutamate receptor ionotropic, NMDA 2CRattus norvegicus (Norway rat)0.263
Glutamate receptor ionotropic, NMDA 1Homo sapiens (human)0.2039
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)0.1
Glutamate receptor ionotropic, NMDA 2BHomo sapiens (human)0.1519
Glutamate receptor ionotropic, NMDA 2DRattus norvegicus (Norway rat)0.263
5-hydroxytryptamine receptor 1AMus musculus (house mouse)0.238
5-hydroxytryptamine receptor 2ABos taurus (cattle)0.61
Glutamate receptor ionotropic, NMDA 3BRattus norvegicus (Norway rat)0.263
Sigma non-opioid intracellular receptor 1Homo sapiens (human)0.0039
Glutamate receptor ionotropic, NMDA 3ARattus norvegicus (Norway rat)0.263

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Agard, DA; Ashworth, A; Barrio-Hernandez, I; Batra, J; Beltrao, P; Bennett, MJ; Bohn, M; Bouhaddou, M; Braberg, H; Broadhurst, DJ; Cai, Y; Cakir, M; Calviello, L; Cavero, DA; Chang, JCJ; Chorba, JS; Craik, CS; d'Enfert, C; Dai, SA; Eckhardt, M; Emerman, M; Fabius, JM; Fletcher, SJ; Floor, SN; Foussard, H; Frankel, AD; Fraser, JS; Fujimori, DG; Ganesan, SJ; García-Sastre, A; Gordon, DE; Gross, JD; Guo, JZ; Haas, K; Haas, P; Hernandez-Armenta, C; Hiatt, J; Huang, XP; Hubert, M; Hüttenhain, R; Ideker, T; Jacobson, M; Jang, GM; Jura, N; Kaake, RM; Kim, M; Kirby, IT; Klippsten, S; Koh, C; Kortemme, T; Krogan, NJ; Kuzuoglu-Ozturk, D; Li, Q; Liboy-Lugo, J; Lin, Y; Liu, X; Liu, Y; Lou, K; Lyu, J; Mac Kain, A; Malik, HS; Mathy, CJP; McGregor, MJ; Melnyk, JE; Memon, D; Meyer, B; Miorin, L; Modak, M; Moreno, E; Mukherjee, S; Naing, ZZC; Noack, J; O'Meara, MJ; O'Neal, MC; Obernier, K; Ott, M; Peng, S; Perica, T; Pilla, KB; Polacco, BJ; Rakesh, R; Rathore, U; Rezelj, VV; Richards, AL; Roesch, F; Rosenberg, OS; Rosenthal, SB; Roth, BL; Roth, TL; Ruggero, D; Safari, M; Sali, A; Saltzberg, DJ; Savar, NS; Schwartz, O; Sharp, PP; Shen, W; Shengjuler, D; Shi, Y; Shoichet, BK; Shokat, KM; Soucheray, M; Stroud, RM; Subramanian, A; Swaney, DL; Taunton, J; Tran, QD; Trenker, R; Tummino, TA; Tutuncuoglu, B; Ugur, FS; Vallet, T; Venkataramanan, S; Verba, KA; Verdin, E; Vignuzzi, M; von Zastrow, M; Wang, HY; Wankowicz, SA; Wenzell, NA; White, KM; Xu, J; Young, JM; Zhang, Z; Zhou, Y1

Other Studies

1 other study(ies) available for vx 497 and ifenprodil

ArticleYear
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.
    Nature, 2020, Volume: 583, Issue:7816

    Topics: Animals; Antiviral Agents; Betacoronavirus; Chlorocebus aethiops; Cloning, Molecular; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Evaluation, Preclinical; Drug Repositioning; HEK293 Cells; Host-Pathogen Interactions; Humans; Immunity, Innate; Mass Spectrometry; Molecular Targeted Therapy; Pandemics; Pneumonia, Viral; Protein Binding; Protein Biosynthesis; Protein Domains; Protein Interaction Mapping; Protein Interaction Maps; Receptors, sigma; SARS-CoV-2; SKP Cullin F-Box Protein Ligases; Vero Cells; Viral Proteins

2020